Inhibrx Biosciences, Inc. INBX Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s net income?
- Inhibrx Biosciences, Inc. (INBX) reported net income of -$33.44M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s net income changed year-over-year?
- Inhibrx Biosciences, Inc.'s net income increased by 22.8% year-over-year, from -$43.31M to -$33.44M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s net income?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s net income has grown at a -23.8% compound annual growth rate (CAGR), from -$241.36M to -$140.06M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.